Aamir Jalal Al-Mosawi
Background: A new therapeutic approach aiming primarily at improving and curing the two major diagnostic features has been recently described. Injectable cerebrolysin was used as the main therapeutic component in this new therapeutic approach. Marked improvement or disappearance of autistic features in these disorders has not been reported with any therapy before. The first book which described the cure of the autistic features was included in Book authority’s lists best books of all time. The aim of this paper is to report the cure of further patients with autism.
Materials and Methods: We have been using a new therapeutic approach aiming at cure of the two major diagnostic features of autism as the standard approach for the treatment of autism disorders in our clinical practice. Courses of intramuscular cerebrolysin were given in individualized regimen depending on the age and severity of the illness, and with aim of improving social interactions including response to name, looking at faces, and eye contact. Most patients were also receiving neuroleptics to control hyperactivity and other abnormal behaviors. It was not possible to record the treatment and follow up of all patients. However, patients included a boy with regressive autism, and a girl with cerebral palsy and autism.
Results: It was possible to document the cure of the two major diagnostic autistic features in another five patients including one girl and four boys.
Conclusion: Cure of the major diagnostic autistic features have been reported previously in thirteen patients. This paper reports the achievement of autistic features cure in another five patients, thus making the total number of documented cure 18 cases